Journals Information
Cancer and Oncology Research(CEASE PUBLICATION) Vol. 2(4), pp. 58 - 67
DOI: 10.13189/cor.2014.020403
Reprint (PDF) (662Kb)
Evaluation of Melanin-Targeted Radiotherapy in Combination with Radiosensitizing Drugs for the Treatment of Melanoma
Sharon Hutchison 1, Colin Rae 1,*, Mathias Tesson 1, John W Babich 2, Marie Boyd 3, Robert J Mairs 1
1 Radiation Oncology, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
2 Department of Radiology, Cornell University, New York, USA
3 Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK
ABSTRACT
The incidence of malignant melanoma is rising faster than that of any other cancer in the United States. An [131I]-labeled benzamide - [131I]MIP-1145 - selectively targets melanin, reduces melanoma tumor burden and increases survival in preclinical models. Our purpose was to determine the potential of radiosensitizers to enhance the anti-tumor efficacy of [131I]MIP-1145. Melanotic (A2058) and amelanotic (A375 and SK-N-BE(2c)) cells were treated with [131I]MIP-1145 as a single agent or in combination with drugs with radiosenitizing potential. Cellular uptake of [131I]MIP-1145 and toxicity were assessed in monolayer culture. The interaction between radiosensitizers and [131I]MIP-1145 was evaluated by combination index analysis in monolayer cultures and by delayed growth of multicellular tumor spheroids. [131I]MIP-1145 was taken up by and was toxic to melanotic cells but not amelanotic cells. Combination treatments comprising [131I]MIP-1145 with the topoisomerase inhibitor topotecan or the PARP-1 inhibitor AG014699 resulted in synergistic clonogenic cell kill and enhanced delay of the growth of spheroids derived from melanotic melanoma cells. The proteasome inhibitor bortezomib had no synergistic cytotoxic effect with [131I]MIP-1145 and failed to enhance the delay of spheroid growth. Following combination treatment of amelanotic cells, neither synergistic clonogenic cell kill nor enhanced growth delay of spheroids was observed.
KEYWORDS
Targeted Radiotherapy, Melanoma, Radiosensitizer
Cite This Paper in IEEE or APA Citation Styles
(a). IEEE Format:
[1] Sharon Hutchison , Colin Rae , Mathias Tesson , John W Babich , Marie Boyd , Robert J Mairs , "Evaluation of Melanin-Targeted Radiotherapy in Combination with Radiosensitizing Drugs for the Treatment of Melanoma," Cancer and Oncology Research(CEASE PUBLICATION), Vol. 2, No. 4, pp. 58 - 67, 2014. DOI: 10.13189/cor.2014.020403.
(b). APA Format:
Sharon Hutchison , Colin Rae , Mathias Tesson , John W Babich , Marie Boyd , Robert J Mairs (2014). Evaluation of Melanin-Targeted Radiotherapy in Combination with Radiosensitizing Drugs for the Treatment of Melanoma. Cancer and Oncology Research(CEASE PUBLICATION), 2(4), 58 - 67. DOI: 10.13189/cor.2014.020403.